Balthasar L Hug

Summary

Affiliation: University Hospital
Country: Switzerland

Publications

  1. doi request reprint Use of hepatotoxic drugs in chronic liver disease
    Balthasar L Hug
    Division of Internal Medicine, Basel University Hospital, Basel, Switzerland
    J Patient Saf 8:45-50. 2012
  2. ncbi request reprint [Nosocomial urinary tract infection in adults]
    B L Hug
    Medizinische Klinik, Universitatsspital Basel, Basel, Schweiz
    Internist (Berl) 47:1151-62. 2006
  3. doi request reprint Mortality and drug exposure in a 5-year cohort of patients with chronic liver disease
    B L Hug
    Division of General Internal Medicine, Brigham and Women s Hospital, Boston, MA, USA
    Swiss Med Wkly 139:737-46. 2009
  4. ncbi request reprint Individualising drug dispensaries in a university hospital
    Balthasar L Hug
    Department of Internal Medicine, University Hospital, CH 4031 Basel, Switzerland
    Swiss Med Wkly 137:62-5. 2007
  5. ncbi request reprint [Somnolence of unknown origin--illness or drug problem?]
    B L Hug
    Medizinische Klinik B, Universitatsspital Basel
    Ther Umsch 63:773-6. 2006
  6. doi request reprint Occurrence of adverse, often preventable, events in community hospitals involving nephrotoxic drugs or those excreted by the kidney
    Balthasar L Hug
    Division of General Internal Medicine, Brigham and Women s Hospital, Boston, Massachusetts 02120 1613, USA
    Kidney Int 76:1192-8. 2009
  7. ncbi request reprint Head-to-head comparison of length of stay, patients' outcome and satisfaction in Switzerland before and after SwissDRG-Implementation in 2012 in 2012: an observational study in two tertiary university centers
    Désirée Thommen
    Division of Internal Medicine, University Hospital Basel, Switzerland
    Swiss Med Wkly 144:w13972. 2014
  8. pmc Adverse drug event rates in six community hospitals and the potential impact of computerized physician order entry for prevention
    Balthasar L Hug
    Division of General Internal Medicine, Brigham and Women s Hospital, Brigham Circle, 1620 Tremont St, 3rd Floor, Boston, MA, 02120 1613, USA
    J Gen Intern Med 25:31-8. 2010
  9. ncbi request reprint The costs of adverse drug events in community hospitals
    Balthasar L Hug
    Division of General Internal Medicine, Brigham and Women s Hospital, Boston, USA
    Jt Comm J Qual Patient Saf 38:120-6. 2012
  10. ncbi request reprint Diagnosis and treatment of iron deficiency in medical inpatients at a Swiss tertiary university referral hospital: a retrospective observational cohort study of clinical practice
    Balthasar L Hug
    Basel University Hospital, Basel, Switzerland
    Swiss Med Wkly 143:w13847. 2013

Collaborators

Detail Information

Publications12

  1. doi request reprint Use of hepatotoxic drugs in chronic liver disease
    Balthasar L Hug
    Division of Internal Medicine, Basel University Hospital, Basel, Switzerland
    J Patient Saf 8:45-50. 2012
    ..In the future, pharmacogenomics and electronic linking of clinical data may well prove helpful for making decisions about optimal drug choices in this complex group of patients...
  2. ncbi request reprint [Nosocomial urinary tract infection in adults]
    B L Hug
    Medizinische Klinik, Universitatsspital Basel, Basel, Schweiz
    Internist (Berl) 47:1151-62. 2006
    ..Comorbidities should be considered and potential obstructions of urinary flow removed. Economically important are the normally higher prices of i.v. antibiotics compared to oral use...
  3. doi request reprint Mortality and drug exposure in a 5-year cohort of patients with chronic liver disease
    B L Hug
    Division of General Internal Medicine, Brigham and Women s Hospital, Boston, MA, USA
    Swiss Med Wkly 139:737-46. 2009
    ..Chronic liver diseases are common in the general population. Drug treatment in this group may be challenging, as many drugs are hepatically metabolised and hepatotoxic...
  4. ncbi request reprint Individualising drug dispensaries in a university hospital
    Balthasar L Hug
    Department of Internal Medicine, University Hospital, CH 4031 Basel, Switzerland
    Swiss Med Wkly 137:62-5. 2007
    ..The interdisciplinary intervention described here took place on three 40-bed wards in a 700-bed university hospital housing patients in general internal medicine, haematology, nephrology and oncology...
  5. ncbi request reprint [Somnolence of unknown origin--illness or drug problem?]
    B L Hug
    Medizinische Klinik B, Universitatsspital Basel
    Ther Umsch 63:773-6. 2006
    ..It is important to realize that three out of four ADEs are estimated to be preventable...
  6. doi request reprint Occurrence of adverse, often preventable, events in community hospitals involving nephrotoxic drugs or those excreted by the kidney
    Balthasar L Hug
    Division of General Internal Medicine, Brigham and Women s Hospital, Boston, Massachusetts 02120 1613, USA
    Kidney Int 76:1192-8. 2009
    ..Our study shows that ADEs were common in patients with impaired kidney function in community hospitals, and many appear potentially preventable with renal dose checking...
  7. ncbi request reprint Head-to-head comparison of length of stay, patients' outcome and satisfaction in Switzerland before and after SwissDRG-Implementation in 2012 in 2012: an observational study in two tertiary university centers
    Désirée Thommen
    Division of Internal Medicine, University Hospital Basel, Switzerland
    Swiss Med Wkly 144:w13972. 2014
    ..With the introduction of the new payment system we aim to answer questions raised regarding length of stay as well as patients' outcome and satisfaction...
  8. pmc Adverse drug event rates in six community hospitals and the potential impact of computerized physician order entry for prevention
    Balthasar L Hug
    Division of General Internal Medicine, Brigham and Women s Hospital, Brigham Circle, 1620 Tremont St, 3rd Floor, Boston, MA, 02120 1613, USA
    J Gen Intern Med 25:31-8. 2010
    ..Medications represent a major cause of harm and are costly for hospitalized patients, but more is known about these issues in large academic hospitals than in smaller hospitals...
  9. ncbi request reprint The costs of adverse drug events in community hospitals
    Balthasar L Hug
    Division of General Internal Medicine, Brigham and Women s Hospital, Boston, USA
    Jt Comm J Qual Patient Saf 38:120-6. 2012
    ....
  10. ncbi request reprint Diagnosis and treatment of iron deficiency in medical inpatients at a Swiss tertiary university referral hospital: a retrospective observational cohort study of clinical practice
    Balthasar L Hug
    Basel University Hospital, Basel, Switzerland
    Swiss Med Wkly 143:w13847. 2013
    ....
  11. doi request reprint Head-to-head comparison of fee-for-service and diagnosis related groups in two tertiary referral hospitals in Switzerland: an observational study
    Noemi Weissenberger
    Division of Internal Medicine, University Hospital Basel, Switzerland
    Swiss Med Wkly 143:w13790. 2013
    ..We compared length of hospital stay (LOS), patient satisfaction and quality of life between the two systems before a nation-wide implementation of DRG...
  12. doi request reprint Drug-related problems: evaluation of a classification system in the daily practice of a Swiss University Hospital
    Markus L Lampert
    Department of Pharmaceutical Sciences, Institute of Clinical Pharmacy, University of Basel, Basel, Switzerland
    Pharm World Sci 30:768-76. 2008
    ..To evaluate the Pharmaceutical Care Network Europe (PCNE) classification system as a tool for documenting the impact of a hospital clinical pharmacology service...